Email this article to a friend
Effects of combined treatment with rapamycin and cotylenin A, a novel differentiation-inducing agent, on human breast carcinoma MCF-7 cells and xenografts
-
* Corresponding author: Takashi Kasukabe kasukabe@cancer-c.pref.saitama.jp
Breast Cancer Research 2005, 7:R1097-R1110 doi:10.1186/bcr1344